The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.
Nasdaq: BMRN
Change
symbol:
     
 PROFILE
If you're feeling something's missing, BioMarin Pharmaceutical can help -- if that something is (alpha)-L-iduronidase. That enzyme is missing in patients with the life-threatening inherited condition mucopolysaccharidosis-I, or MPS-I. Because only 3,400 known patients suffer from the disease, the company's treatment, Aldurazyme, has received orphan drug status from the FDA. This gives the development-stage firm exclusive seven-year rights to market Aldurazyme if it is the first enzyme for MPS-1 that is OK'd by the FDA. The company will market the drug through a joint venture with Genzyme. BioMarin, of which Glyko Biomedical owns about 30%, is also developing enzymes that target burns.

 COMPETITION
BioCryst Pharmaceuticals, Inc. (BCRX)
Biospecifics Technologies Corp. (BSTC)
Enzon, Inc. (ENZN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 12.30
1-Yr. Sales Growth: 75.7%
Employees: 174
Revenue per employee: $70,689.66

 KEY PEOPLE
• Fredric D. Price
    CEO
• Raymond W. Anderson
    CFO

 CONTACT INFO
371 Bel Marin Keys Blvd., Ste. 210
Novato, CA 94949
US
Phone: 415-884-6700
Fax: 415-382-7427
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001